Please wait while we open this resource.
K
Clinical reviews
TIRZEPATIDE AND PREVENTION OF CHRONIC KIDNEY DISEASE
Instituto Universitario CEMIC, Buenos Aires, Argentina; Department of Nephrology and Hypertension, IIS-Fundacion Jimenez Diaz UAM, Madrid, Spain; Vall d’Hebron University Hospital, Vall d’Hebron Institute of Research, Barcelona, Spain; Universidad
PDF12 pages2.3 MB
Tirzepatide has been recently approved for improving glycemic control in T2DM and shows promise in reducing cardiorenal risk factors. Clinical trials indicate that it may decrease albuminuria and slow the decline of estimated glomerular filtration rate (eGFR) in high-risk populations. The document discusses ongoing research and trials assessing its impact on cardiovascular events and kidney health, positioning tirzepatide as a potential therapeutic option for patients with T2DM and CKD.
Sign in to open
Ask this resource
Answers use this document only.
Your first question is free.
More like this
Resources from the same specialty and type. Curated links will replace these when added.
Clinical Resources
Documents that extend or complement this resource.
CARDIOVASCULAR COMPLICATIONS IN CHRONIC KIDNEY DISEASE: A REVIEW FROM THE EUROPEAN RENAL AND CARDIOVASCULAR MEDICINE WORKING GROUP OF THE EUROPEAN RENAL ASSOCIATION
Same clinical topic · Nephrology
THE ASSOCIATION BETWEEN DUAL RAAS INHIBITION AND RISK OF ACUTE KIDNEY INJURY AND HYPERKALEMIA IN PATIENTS WITH DIABETIC KIDNEY DISEASE: A SYSTEMATIC REVIEW AND META-ANALYSIS
Same clinical topic · Nephrology
OBESITY IN CKD: CORE CURRICULUM 2026
Same clinical topic · Nephrology
OBESITY IN CKD: CORE CURRICULUM 2026
Same clinical topic · Nephrology
ACUTE GLOMERULONEPHRITIS
Same clinical topic · Nephrology
DISEASE MODIFICATION IN LUPUS NEPHRITIS: TOWARDS A PATHOPHYSIOLOGY-BASED TREATMENT PARADIGM
Same clinical topic · Nephrology
Effects of correction rate for severe hyponatremia in the intensive care unit on patient outcomes
Same clinical topic · Nephrology
CURRENT UNDERSTANDING OF SODIUM-GLUCOSE TRANSPORTER 2 INHIBITORS IN CARDIOVASCULAR-KIDNEY-METABOLIC SYNDROME
Same clinical topic · Nephrology
A COMPREHENSIVE REVIEW OF ACUTE CARDIO-RENAL SYNDROME: NEED FOR NOVEL BIOMARKERS
Same clinical topic · Nephrology